Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer

Molecular Cell

Volumn 1, Issue 6, 1998, Pages 841-848

  Holt, Kathleen H ^a   Lim, Leland E ^a   Straub, Volker ^a   Venzke, David P ^a   Duclos, Franck ^a   Anderson, Richard D ^a   Davidson, Beverly L ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SARCOGLYCAN;

ADENOVIRUS; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CHEMISTRY; CYTOLOGY; GENE TRANSFER; GENETICS; HAMSTER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROINJECTION; MUSCLE CELL; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMID; SARCOLEMMA; SKELETAL MUSCLE;

ADENOVIRIDAE; ANIMALS; CRICETINAE; CYTOSKELETAL PROTEINS; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MEMBRANE GLYCOPROTEINS; MICROINJECTIONS; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUTATION; PLASMIDS; RECOMBINANT PROTEINS; SARCOGLYCANS; SARCOLEMMA;

EID: 0032062510     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80083-0     Document Type: Article

References (36)

1. Acsadi, G., Dickson, G., Love, D.R., Jani, A., Walsh, F.S., Gurusinghe, A., Wolff, J.A.,and Davies, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.
2. Allamand, V., Sunada, Y., Salih, M.A., Straub, V., Ozo, C.O., Al-Turaiki, M.H., Akbar, M., Kolo, T., Colognato, H., Zhang, X., et al. (1997). Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum. Mol. Genet. 6, 747-752.
3. Bönneman, C.G., Modi, R., Noguchi, S., Mizuno, Y., Yoshida, M., Gussoni, E., McNally, E.M., Duggan, D.J., Angelini, C., Hoffman, E.P., et al. (1995). β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat. Genet. 11, 266-273.
4. Campbell, K.P. (1995). Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
5. Crosbie, R.H., Heighway, J., Venzke, D.P., Lee, J.C., and Campbell, K.P. (1997). Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J. Biol. Chem. 272, 31221-31224.
6. Danko, I., Fritz, J.D., Latendresse, J.S., Herweijer, H., Schultz, E., and Wolff, J.A. (1993). Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum. Mol. Genet. 2, 2055-2061.
7. Davidson, B.L., Doran, S.E., Shewach, D.S., Latta, J.M., Hartman, J.W., and Roessler, B.J. (1994). Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Maca mulatta following adenoviral mediated gene transfer. Exp. Neurol. 125, 258-267.
8. Ervasti, J.M., and Campbell, K.P. (1991). Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.
9. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G., and Campbell, K.P. (1990). Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315-319.
10. Fritz, J.D., Danko, I., Roberds, S.L., Campbell, K.P., Latendresse, J.S., and Wolff, J.A. (1995). Expression of deletion-containing dystrophins in mdx muscle: implications for gene therapy and dystrophin function. Pediatr. Res. 37, 693-700.
11. Grady, R.M., Teng, H., Nichol, M.C., Cunningham, J.C., Wilkinson, R.S., and Sanes, J.R. (1997). Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729-738.
12. Graham, F.L., and van der Eb, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
13. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tome, F.M.S., Schwartz, K., Fardeau, M., Tryggvason, K., and Guicheney, P. (1995). Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11, 216-218.
14. Hoffman, E.P., Brown, R.H., Jr., and Kunkel, L.M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
15. Homburger, F., Baker, J.R., Nixon, C.W., and Whitney, R. (1962). Primary, generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters. Med. Exp. 6, 339-345.
16. Iwata, Y., Nakamura, H., Mizuno, Y., Yoshida, M., Ozawa, E., and Shigekawa, M. (1993). Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart. FEBS Lett. 329, 227-231.
17. Jung, D., Leturcq, F., Sunada, Y., Duclos, F., Tomé, F.M.S., Moomaw, C., Merlini, L., Azibi, K., Chaoch, M., Slaughter, C., et al. (1996a). Absence of γ-sarcoglycan (35DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett. 381, 15-20.
18. Jung, D., Duclos, F., Apostol, B., Straub, V., Lee, J.C., Allamand, V., Venzke, D.P., Sunada, Y., Moomaw, C.R., Leveille, C.J., et al. (1996b). Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J. Biol. Chem. 271, 32321-32329.
19. Lim, L.E., Duclos, F., Broux, O., Bourg, N., Sunada, Y., Allamand, V., Meyer, J., Richard, I., Moomaw, C., Slaughter, C., et al. (1995). β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat. Genet. 11, 257-265.
20. Matsuda, R., Nishikawa, A., and Tanaka, H. (1995). Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. (Tokyo) 118, 959-964.
21. McNeil, P.L., and Steinhardt, R.A. (1997). Loss, restoration, and maintenance of plasma membrane integrity. J. Cell Biol. 137, 1-4.
22. Monaco, A.P., Neve, R.L., Colletti-Feener, C., Bertelson, C.J., Kurnit, D.M., and Kunkel, L.M. (1986). Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646-650.
23. Nigro, V., Piluso, G., Belsito, A., Politano, L., Puca, A.A., Papparella, S., Rossi, E., Viglietto, G., Esposito, M.G., Abbondanza, G., et al. (1996a). Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum. Mol. Genet. 5, 1179-1186.
24. Nigro, V., Moreira, E.D., Piluso, G., Vainzof, M., Belsito, A., Politano, L., Puca, A.A., Passos-Bueno, M.R., and Zatz, M. (1996b). Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat. Genet. 14, 195-198.
25. Nigro, V., Okazaki, Y., Belsito, A., Piluso, G., Matsuda, Y., Politano, L., Nigro, G., Ventura, C., Abbondanza, C., Molinari, A.M., et al. (1997). Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601-607.
26. Noguchi, S., McNally, E.M., Othmane, K.B., Hagiwara, Y., Mizuno, Y., Yoshida, M., Yamamoto, H., Bönneman, C.G., Gussoni, E., Denton, P.H., et al. (1995). Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science 270, 819-822.
27. Okazaki, Y., Okuizumi, H., Ohsumi, T., Nomura, O., Takada, S., Kamiya, M., Sasaki, N., Matsuda, Y., Nishimura, M., Tagaya, O., et al. (1996). A genetic linkage map of the Syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping. Nat. Genet. 13, 87-90.
28. Ozawa, E., Yoshida, M., Suzuki, A., Mizuno, Y., Hagiwara, Y., and Noguchi, S. (1995). Dystrophin-associated proteins in musculardystrophy. Hum. Mol. Genet. 4, 1711-1716.
29. Passos-Bueno, M.R., Moreira, E.S., Vainzof, M., Marie, S.K., and Zatz, M. (1996). Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR-LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD. Hum. Mol. Genet. 5, 815-820.
30. Piccolo, F., Roberds, S.L., Jeanpierre, M., Leturcq, F., Azibi, K., Beldford, C., Carrie, A., and Recan, D. (1995). Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat. Genet. 5, 1963-1969.
31. Roberds, S.L., Anderson, R.D., Ibraghimov-Beskrovnaya, O., and Campbell, K.P. (1993a). Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (Adhalin). J. Biol. Chem. 268, 23739-23742.
32. Roberds, S.L., Ervasti, J.M., Anderson, R.D., Ohlendieck, K., Kahl, S.D., Zoloto, D., and Campbell, K.P. (1993b). Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J. Biol. Chem. 268, 11496-11499.
33. Roberds, S.L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R.D., Lim, L.E., Lee, J.C., Tome, F.M.S., Romero, N.B., et al. (1994). Missense mutations in the α-sarcoglycan gene linked to autosomal recessive muscular dystrophy. Cell 78, 625-633.
34. Sakamoto, A., Ono, K., Abe, M., Jasmin, G., Eki, T., Murakami, Y., Masaki, T., Yoyo-oka, T., and Hanaoka, F. (1997). Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA 94, 13873-13878.
35. Straub, V., and Campbell, K.P. (1997). Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168-175.
36. Straub, V., Rafael, J.A., Chamberlain, J.S., and Campbell, K.P. (1997). Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385.